COMP <GO>
CRSP vs RLAY // EV/EBITDA & P/E VALUATION
CRISPR Therapeutics AG (NASDAQ) VS. Relay Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CRSP 3
— RLAY 2
■ METRIC PARITY
LAST: $54.26 (+0.28%) • MKT CAP: $5.25B
valuation
—
LAST: $19.47 (-1.12%) • MKT CAP: $4.27B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRSP VS. RLAY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRSP | RLAY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -30.60% | -35.00% | +4.40 | CRSP | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.59% | -5.53% | -1.06 | RLAY | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 53.40% | -118.40 | RLAY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.97 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.9 | 50.0 | +4.91 | CRSP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.25B | $4.27B | $979.9M | CRSP | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRSP REV | RLAY REV | CRSP GROSS % | RLAY GROSS % | CRSP FCF | RLAY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.5M | $15.4M | — | — | -$345.9M | -$235.9M |
| FY 2024 | $37.3M | $10.0M | — | — | -$144.7M | -$251.1M |
| FY 2023 | $371.2M | $25.5M | — | — | -$277.1M | -$300.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRSP // BETA 1.12
RLAY // BETA —